PathAI logo

KRAS Mutation Analysis (NGS)

Next Generation Sequencing (NGS) · Dermatology
The KRAS Mutation Analysis (Solid Tumor FFPE) assay uses next-generation sequencing (NGS) technology to provide an assessment of the KRAS gene for the detection of genetic alterations within select regions of exons 2, 3, and 4 in human genomic DNA isolated from formalin-fixed paraffin-embedded (FFPE) tissue.